Suppr超能文献

[接受持续肾脏替代治疗的急性肾损伤患者的抗假单胞菌抗生素剂量]

[Dosage of antipseudomonal antibiotics in patients with acute kidney injury subjected to continuous renal replacement therapies].

作者信息

Carcelero San Martín E, Soy Muner D

机构信息

Servicio de Farmacia, Hospital Clínic Barcelona, Barcelona, España.

出版信息

Med Intensiva. 2013 Apr;37(3):185-200. doi: 10.1016/j.medin.2012.02.012. Epub 2012 Apr 3.

Abstract

Critically ill patients are often affected by infections produced by Pseudomonas, which can be a cause of sepsis and renal failure. Early and adequate antibiotic treatment at correct dosage levels is crucial. Acute kidney injury is also frequent in critically ill patients. In those patients who require renal replacement therapy, continuous techniques are gaining relevance as filtering alternatives to intermittent hemodialysis. It must be taken into account that many antibiotics are largely cleared by continuous renal replacement therapies (CRRT). The aim of this review is to assess the clinical evidence on the pharmacokinetics and dosage recommendations of the main antibiotic groups used to treat Pseudomonas spp. infections in critically ill patients subjected to CRRT.

摘要

重症患者常受铜绿假单胞菌感染影响,这可能是败血症和肾衰竭的一个病因。以正确剂量水平进行早期且充分的抗生素治疗至关重要。急性肾损伤在重症患者中也很常见。在那些需要肾脏替代治疗的患者中,连续性技术作为间歇性血液透析的过滤替代方法正变得越来越重要。必须考虑到许多抗生素在很大程度上会被连续性肾脏替代治疗(CRRT)清除。本综述的目的是评估关于用于治疗接受CRRT的重症患者铜绿假单胞菌属感染的主要抗生素组的药代动力学和剂量推荐的临床证据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验